- Alphatec Holdings, Inc. (ATEC, Financial) reports a 22% increase in total revenue for Q1 2025.
- Full-year revenue guidance increased to $734 million with a 20% expected growth.
- ATEC successfully refinances convertible debt to 2030 maturity.
Alphatec Holdings, Inc. (ATEC), a leader in innovative spine surgery solutions, announced its financial results for the first quarter ending March 31, 2025. ATEC reported a total revenue of $169 million, marking a 22% increase from the previous year. Surgical revenue led this growth, rising by 24% to $152 million, which was bolstered by a 17% increase in procedural volume.
The gross margin for the quarter stood at 69% on a GAAP basis and 70% on a non-GAAP basis. Operating expenses were reported at $160 million under GAAP, while non-GAAP operating expenses were $124 million. The net loss for the quarter was reported at $52 million, but the company achieved an adjusted EBITDA of $11 million, reflecting a 6% margin.
Key highlights include an 18% growth in new surgeon adoption and an improved adjusted EBITDA margin by 840 basis points year-over-year through strategic cost management. Furthermore, ATEC improved its free cash use by $55 million compared to the first quarter of the previous year.
Looking ahead, ATEC has raised its full-year revenue guidance to $734 million, which includes surgical revenue of $658 million and EOS revenue of $76 million. The company also increased its non-GAAP adjusted EBITDA forecast to approximately $78 million.
ATEC continues to focus on its spine-only approach, which has positioned it as a preferred destination in the spine surgery sector. The company also mentioned its successful refinancing of convertible debt to a 2030 maturity, which strengthens its financial position.
A live webcast discussing these results will be available on ATEC’s Investor Relations Section of their corporate website. A replay will remain accessible for twelve months.
